High-yield discussion of pharmacotherapy in rheumatoid arthritis; includes choice of the drug based on the stage of disease management (Non-DMARDs, conventional DMARDs, Biological DMARDs including TNF-inhibitors & non-TNF inhibitors); 

The understanding of the medication choice, their side effects and pretreatment or follow up assessment is essential for many other rheumatology chapters in internal medicine & pediatrics (including seronegative spondyloarhtropathies, vasculitis arthritis, Juvenile Idiopathic Arthritis)